Cellebrite officer plans sale of 5,673 shares

The planned sale is limited to shares needed to cover income tax liabilities from vested restricted share unit awards.

Available on EDGAR 11/10/2026 - 06:15 AM EST Accepted by SEC EDGAR 11/10/2026 - 06:15 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cellebrite DI Ltd. officer David Gee intends to sell 5,673 ordinary shares on November 23, 2026, under a mandatory, non-discretionary sell-to-cover arrangement. The shares came from restricted share units that vested on November 20, 2026, under an issuer S-8 registered plan; the stated purpose is to satisfy income tax liabilities incurred upon vesting of those awards only.

Key Figures

Intended sale: 5,673 shares Vested restricted share units: 5,673 shares Aggregate market value: 72,047.1 aggregate market value +1 more

4 metrics

Intended sale 5,673 shares November 23, 2026

Vested restricted share units 5,673 shares Vested November 20, 2026 under an issuer S-8 registered plan

Aggregate market value 72,047.1 aggregate market value For the shares proposed for sale

Ordinary shares outstanding 251,341,060 shares Reported in the securities information

Key Terms

sell-to-cover arrangement, Restricted Share Units, S-8 Registered Plan

3 terms

sell-to-cover arrangement financial

"mandatory, non-discretionary, sell-to-cover arrangement"

Restricted Share Units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 Registered Plan regulatory

"under an Issuer S-8 Registered Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLBT shares does David Gee plan to sell?

David Gee intends to sell 5,673 ordinary shares on November 23, 2026. The notice describes the sale as a mandatory, non-discretionary sell-to-cover arrangement for income tax liabilities incurred upon vesting of restricted share unit awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001547134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972733948000
Name of Person for Whose Account the Securities are To Be Sold	David Gee
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5673	72047.1	251341060	11/23/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	11/20/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	CELLEBRITE DI LTD.			5673	11/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	08/12/2026	230	3695.59
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	08/21/2026	2198	24709.03
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	08/24/2026	4323	49111.44

144: Remarks and Signature

Remarks	The reporting person intends to sell securities reported herein on 11/23/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Gee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)